1. Home
  2. VRA vs ABOS Comparison

VRA vs ABOS Comparison

Compare VRA & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.21

Market Cap

92.0M

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.26

Market Cap

155.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
ABOS
Founded
1982
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.0M
155.7M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
VRA
ABOS
Price
$3.21
$2.26
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
N/A
$7.75
AVG Volume (30 Days)
467.6K
532.0K
Earning Date
03-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$416,097,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.86
52 Week High
$3.80
$3.60

Technical Indicators

Market Signals
Indicator
VRA
ABOS
Relative Strength Index (RSI) 54.24 31.48
Support Level $1.87 $2.21
Resistance Level $3.33 $2.42
Average True Range (ATR) 0.28 0.28
MACD 0.01 -0.12
Stochastic Oscillator 59.31 1.68

Price Performance

Historical Comparison
VRA
ABOS

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: